Single Nucleotide Polymorphisms (Snps) GATCTGTATGCCTACTAGAAGATCGAT GATCTGTATGCCTACGAGAAGATCGAT

Single Nucleotide Polymorphisms (Snps) GATCTGTATGCCTACTAGAAGATCGAT GATCTGTATGCCTACGAGAAGATCGAT

Genomics Genomics in Medicine, part II Overview Impact of the Human Genome Project (HGP) Molecular Basis of Disease SNPs and Diagnostics Drug design, drug efficacy, and adverse drug effects Imatinib, part II http://www.ncbi.nlm.nih.gov/projects/genome/guide/human/ Impact of the Human Genome Project: Opportunities to • understand the molecular basis of disease (monogenic vs. polygenic basis of disease) • understand biochemical pathways and metabolism • design novel molecular diagnostics • develop novel therapeutics (e.g., drug target discovery, gene therapy) Molecular basis of disease Chronic myeloid leukemia: Specific chromosomal abnormality called the Philadelphia (Ph) chromosome contained within affected cells. Ph chromosome results from translocation (exchange of genetic material) between chromosomes 9 and 22 . This exchange brings together two genes: the BCR (breakpoint cluster region) gene on chromosome 22 and the proto-oncogene ABL (Ableson leukemia virus) on chromosome 9 to produce a hybrid gene called BCR-ABL. Hybrid gene encodes a fusion protein with tyrosine kinase activity, which activates signal transduction pathways, leading to uncontrolled cell growth. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/gnd/gnd.pdf Monogenic basis of disease Disease caused by modifications in a SINGLE gene Three categories of monogenic diseases: Dominant (one bad copy disease) Recessive (both copies must be defective) X-linked (may be dominant or recessive; expressed in both sexes, but more so in males due to presence of one X (vs. two X’s in females) Examples: α and β thalassaemias are most common single gene disorders globally; fragile X syndrome, sickle cell anemia, cystic fibrosis, haemophilia) Single Nucleotide Polymorphisms (SNPs) GATCTGTATGCCTACTAGAAGATCGAT GATCTGTATGCCTACGAGAAGATCGAT Individual’s genomes differ from each other by 0.1%. There are at least 10 million polymorphic sites in the human genome. SNPs can distinguish individuals from one another. SNPs can be used to diagnose disease. Single Nucleotide Polymorphisms (SNPs) •Most SNPs have no known effect •Rarely a single SNP is responsible for the disease state •Some SNPs predispose an individual to disease •Some SNPs can be used to determine drug efficacy •Some SNPs can be used to determine adverse drug effects (want to choose the right medicine for the right patient) SNPs can be used to diagnose disease http://cmgm.stanford.edu/~brutlag/Presentations/Genomics_&_Medicine.pdf http://cmgm.stanford.edu/~brutlag/Presentations/Genomics_&_Medicine.pdf Go to www.ascb.org for iBioSeminar by Dr. Brian Druker, part III.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us